COVID-19 vaccine from AstraZeneca-Oxford slightly less effective than first touted: 76% rather than 79% against disease, updated data shows

https://ift.tt/2ODy7kR

More recent clinical trial results show AstraZeneca's COVID-19 vaccine is slightly less effective in stopping disease than the company first reported.

     


from USATODAY - News Top Stories COVID-19 vaccine from AstraZeneca-Oxford slightly less effective than first touted: 76% rather than 79% against disease, updated data shows
Karen Weintraub, USA TODAY

More recent clinical trial results show AstraZeneca's COVID-19 vaccine is slightly less effective in stopping disease than the company first reported.

     

March 25, 2021 at 01:34AM
https://ift.tt/2UWK6IU
https://ift.tt/3vU7RmW

Popular Posts